|
|
| | N-(4-chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-Indazol-6-amine Basic information |
| Product Name: | N-(4-chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-Indazol-6-amine | | Synonyms: | N-(4-chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-Indazol-6-amine;(4-Chloro-pyrimidin-2-yl)-(2,3-dimethyl-2H-indazol-6-yl)-methyl-amine;2H-Indazol-6-amine, N-(4-chloro-2-pyrimidinyl)-N,2,3-trimethyl-;N-(4-chloropyrimidin-2-yl)-N,2,3-trimethyl-2H-indazol-6-amine; Parahappani impurity 50;Pazopanil Impurity 50;PAZ-IMPURITY 2 | | CAS: | 1252927-45-9 | | MF: | C14H14ClN5 | | MW: | 287.75 | | EINECS: | | | Product Categories: | | | Mol File: | 1252927-45-9.mol |  |
| | N-(4-chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-Indazol-6-amine Chemical Properties |
| Melting point | 151-153 °C(Solvent: Isopropanol) | | Boiling point | 497.8±53.0 °C(Predicted) | | density | 1.33±0.1 g/cm3(Predicted) | | pka | 2.96±0.30(Predicted) |
| | N-(4-chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-Indazol-6-amine Usage And Synthesis |
| Uses | N-(4-Chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-indazol-6-amine is an intermediate in the synthesis of 5-((2-((2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-4-yl)amino)-2-methylbenzenesulfonamide Hydrochloride (D474433) which is an impurity of Pazopanib (P210925), which is an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
| | N-(4-chloro-2-pyrimidinyl)-N,2,3-trimethyl-2H-Indazol-6-amine Preparation Products And Raw materials |
|